CJC-1295 (without DAC)

Overview

CJC-1295 (without DAC) is a synthetic peptide analog of growth-hormone-releasing hormone (GHRH) that has been studied exclusively under non-clinical laboratory conditions. Preclinical research examines its effects on cellular signaling pathways related to growth-hormone release, pituitary function, and metabolic regulation within controlled in vitro and animal models. The information provided summarizes scientific investigation only and is not intended as guidance for human use or clinical application.

Specifications

• Unit Size: 10 mg per vial

• Form: Lyophilized powder

• Storage: Store dry at 2 °C–8 °C. After reconstitution, refrigerate at 2 °C–8 °C and use within 10–14 days.

• Documentation: Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS) available on request.

Research Context

In vitro and preclinical models have explored CJC-1295 (no DAC) in relation to:

• Regulation of growth-hormone and IGF-1 signaling pathways

• Pituitary cell responses to growth-hormone-releasing factors

• Interactions with GHRH receptors in metabolic and stress-response pathways

• Short-acting peptide kinetics and bio-signaling mechanisms under laboratory conditions

All references to biological activity reflect controlled research contexts only and should not be interpreted as claims of safety or efficacy in humans or animals.

Intended Use / Restrictions

• For laboratory research use only

• Not for human or veterinary use

• Not a drug, dietary supplement, or medical device

• Purchasers must be qualified researchers or institutions and assume full responsibility for compliance with all applicable laws and regulations.

Important Notice

The seller makes no claims that this material is safe or effective for any form of administration in humans or animals. All information is provided strictly for educational and scientific purposes. Buyers must ensure lawful handling, storage, and disposal in accordance with institutional biosafety standards.